Frost & Sullivan's Award underlined Mindray's Innovative practice
Mindray, based in Shenzhen, China, was founded in 1991. The company's success has been built on innovation in the past 20 years. Started as a supplier of patient monitors, the company gradually expanded its business to in-vitro diagnostics, ultrasound, radiographic equipment and ICU/OR overall solution etc. In 2010, the company received China Food and Drug Administration approval to launch its BeneHeart D6 biphasic defibrillator, which made Mindray the first domestic medical equipment enterprise to manufacture such product. Compared with some foreign brand machines in the market, Mindray's BeneHeart D6 biphasic defibrillator is reliable, user friendly, and equipped with innovative data transmission systems and multi-parameter monitoring functions.
Report from Frost & Sullivan indicates, besides its competitive technologies, Mindray also excels in both product line planning and marketing methods innovation. Mindray's growth strategies have resulted in outstanding sales performance in both urban and rural health care markets in China, as well as countries overseas.
Open WeChat and Scan the QR code .Get the Webpage and Share on Moments.
Mindray Chairman's Statement on Efforts to Combat COVID-192020-04-05
Sii Forte Italia! From Mindray, with All Our Efforts to Support2020-04-03
Mindray Makes Donations to Designated Hospitals for COVID-19 in Wuhan2020-03-05
Mindray in Action to Combat COVID-192020-02-24
Mindray Showcases Latest Medical Innovations at Arab Health & Medlab Middle East 20202020-02-07